HKSE:08049'
s Operating Margin % Range Over the Past 10 Years
Min: 18.25 Med: 21.94 Max: 24.26
Current: 23.78
HKSE:08049's Operating Margin % is ranked better than 88.35% of 953
companies
in the Drug Manufacturers industry
Industry Median: 7.57
vs HKSE:08049: 23.78
Jilin Province Huinan Changlong Bio-pharmacy Co (HKSE:08049) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Jilin Province Huinan Changlong Bio-pharmacy Co Operating Margin % Related Terms
Jilin Province Huinan Changlong Bio-pharmacy Co Operating Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jilin Province Huinan Changlong Bio-pharmacy Co Operating Margin % Chart
Jilin Province Huinan Changlong Bio-pharmacy Co Annual Data
HKSE:08049 vs ZTS, UTHR: Operating Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Jilin Province Huinan Changlong Bio-pharmacy Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jilin Province Huinan Changlong Bio-pharmacy Co Operating Margin % vs Drug Manufacturers Industry
Jilin Province Huinan Changlong Bio-pharmacy Co Operating Margin % Calculation
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jilin Province Huinan Changlong Bio-pharmacy Co (HKSE:08049) has a Operating Margin % of 21.72% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on Jilin Province Huinan Changlong Bio-pharmacy Co and its competitors. This is near median its historical median of 21.94. Over the past decade, Jilin Province Huinan Changlong Bio-pharmacy Co's Operating Margin % has ranged from 18.25 to 24.26. According to the industry distribution chart, Jilin Province Huinan Changlong Bio-pharmacy Co ranks #111 out of 953 companies in the Drug Manufacturers industry, placing it in the top 11.6%.
Is Jilin Province Huinan Changlong Bio-pharmacy Co's Operating Margin % too high?
Jilin Province Huinan Changlong Bio-pharmacy Co's current Operating Margin % of 21.72% is near median its 10-year median of 21.94. Over the past 10 years, this metric has ranged from a low of 18.25 to a high of 24.26. The Drug Manufacturers industry median Operating Margin % is 7.57. Jilin Province Huinan Changlong Bio-pharmacy Co's value of 21.72% is 186.9% above this industry median. Based on the distribution chart, Jilin Province Huinan Changlong Bio-pharmacy Co ranks #111 out of 953 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Jilin Province Huinan Changlong Bio-pharmacy Co has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jilin Province Huinan Changlong Bio-pharmacy Co's Operating Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Jilin Province Huinan Changlong Bio-pharmacy Co ranks #111 out of 953 companies for Operating Margin %. This places Jilin Province Huinan Changlong Bio-pharmacy Co in the top 12% of its industry — outperforming the majority of peers. The industry median Operating Margin % is 7.57. Jilin Province Huinan Changlong Bio-pharmacy Co's value of 21.72% is 186.9% above this benchmark. Historically, Jilin Province Huinan Changlong Bio-pharmacy Co's own Operating Margin % has ranged from 18.25 to 24.26 over the past decade. While the company's 10-year median is 21.94 vs. the industry median of 7.57, Jilin Province Huinan Changlong Bio-pharmacy Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Drug Manufacturers company?
The median Operating Margin % among Drug Manufacturers companies is 7.57, based on 953 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jilin Province Huinan Changlong Bio-pharmacy Co's current Operating Margin % of 21.72% is 186.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Jilin Province Huinan Changlong Bio-pharmacy Co and its competitors. For the Drug Manufacturers industry, the median Operating Margin % is 7.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jilin Province Huinan Changlong Bio-pharmacy Co's current Operating Margin % is 21.72%, which is near median its own 10-year median of 21.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jilin Province Huinan Changlong Bio-pharmacy Co stock overvalued right now?
Based on GuruFocus' analysis, Jilin Province Huinan Changlong Bio-pharmacy Co (HKSE:08049) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$1.66, compared to a current price of HK$2.31 — trading 39.2% above its estimated fair value. The current Operating Margin % is 21.72%, which is near median its 10-year median of 21.94 and 186.9% above the Drug Manufacturers industry median of 7.57. Jilin Province Huinan Changlong Bio-pharmacy Co's overall GF Score™ is 81/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Jilin Province Huinan Changlong Bio-pharmacy Co (HKSE:08049), the current Operating Margin % is 21.72% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jilin Province Huinan Changlong Bio-pharmacy Co (HKSE:08049) Overvalued in 2026?
Based on GuruFocus' analysis, Jilin Province Huinan Changlong Bio-pharmacy Co stock appears to be overvalued.
The current stock price of HK$2.31 is trading 39.2% above its estimated GF Value™ of HK$1.66.
GuruFocus considers Jilin Province Huinan Changlong Bio-pharmacy Co to be Significantly Overvalued.
Key valuation signals for HKSE:08049:
Operating Margin %: 21.72% (near median its 10-year median of 21.94)
GF Value™: HK$1.66 vs. price of HK$2.31 (39.2% above fair value)
Industry Position: 186.9% above the Drug Manufacturers median (#111 of 953)
No single metric tells the full story. See the HKSE:08049 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jilin Province Huinan Changlong Bio-pharmacy Co Business Description
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd is principally engaged in the manufacture and distribution of Chinese medicines and pharmaceutical products in the PRC under the brand names of Changlong and Qing Tong. The company has only one business segment. It generates revenue from the Sales of Chinese medicines and pharmaceutical products. Geographically, it derives its entire revenue from the PRC.
81GF Score
Get the complete analysis for HKSE:08049
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08049 has been successfully added to your 
